Qualigen Therapeutics, Inc. Reports Third Quarter 2021 Financial Results
Quarterly revenues increased 38% to approximately $1.2 million, compared to approximately $0.8 million in the same quarter of the previous...
Day: November 15, 2021
Revelation Biosciences Inc. Announces Initiation of a Phase 1b Clinical Study of REVTx-99 for the Experimental Treatment of Allergic Rhinitis and Chronic Nasal Congestion
-Top-line data anticipated in the first quarter of 2022-SAN DIEGO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (Revelation),...
Ram Yeleswarapu to drive growth for Indegene Clinical and enable healthcare organizations digitalize their clinical development
PRINCETON, N.J. and BANGALORE, India., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Ram Yeleswarapu, a leading executive with over 25 years...
AnaptysBio Announces Positive Rosnilimab Healthy Volunteer Phase 1 Top-Line Data
Rosnilimab, AnaptysBio’s wholly-owned anti-PD-1 agonist antibody, demonstrated favorable safety and tolerability in single and multiple ascending dose healthy volunteer cohortsRobust...
Castellum, Inc. Announces Record Financial Results
Castellum, Inc. Announces Record Financial Results OTC:ONOV - Revenue for Q3 2021 was a record $7.38 million. Adjusted EBITDA (excluding...
Assure Holdings Announces Closing $4.75 Million Private Placement to Accelerate 2022 Growth
Gross proceeds of $4.75 million at an issue price of $5.25/share with no warrants in a private placement raised from...
Clene Announces Completion of Patient Enrollment in the HEALEY ALS Platform Trial
Registration trial for CNM-Au8®, a gold nanocrystal suspensionTopline data anticipated 2H 2022World’s first ALS platform trial accelerating the path to...
Kala Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update
-- Achieved $3.1 Million in Net Revenue in 3Q 2021 ---- EYSUVIS® Prescriptions Increased by 19% Compared to 2Q 2021--...
Kala Pharmaceuticals Acquires Combangio, Expanding its Pipeline with a Clinical-Stage Novel Biologic for the Treatment of Persistent Corneal Epithelial Defect (PCED) and other Rare Ocular Surface Diseases
-- KPI-012 is a novel secretome with a multifactorial mechanism of action for development in PCED and other orphan ocular...
FDA Commences Review of Cell MedX’s Premarket Notification (510K) and Health Canada Renews Class II Medical Device Licenses for eBalance(R) Systems
Carson City, Nevada--(Newsfile Corp. - November 15, 2021) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a...
Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete First Evaluation Under a Health Canada Approved cGMP Laboratory
Red Light Holland is continuing its groundbreaking working synergies with Shaman Pharma Corp. and their cGMP laboratory partner, CCrest Laboratories...
Netsmart and American Society of Addiction Medicine Announce Partnership to Integrate ASAM CONTINUUM System
OVERLAND PARK, Kan.--(BUSINESS WIRE)--#ASAM--Netsmart, an industry-leading provider of healthcare technology solutions and services, today announced a strategic partnership with the...
Pear Therapeutics Provides 2021 Business Update and Reaffirms Full Year 2021 Revenue Guidance
BOSTON--(BUSINESS WIRE)--Pear Therapeutics, Inc. (“Pear”), the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs), today provides...
Abdul Latif Jameel Health and Butterfly Network enter strategic distribution partnership to bring Butterfly iQ+ ultrasound device to a potential 2 billion1 people across the Middle East, North Africa, Turkey & India
The Butterfly iQ+ is the world’s only single-probe, whole-body, handheld imaging device with the potential to bring medical imaging to...
InfuSystem Reports Third Quarter 2021 Financial Results
Selected as Supplier of Infusion Pump Biomedical Services for Leading Global Medical Technology and Diagnostic Equipment Company Worth Expected $14...
Biophytis Announces US Centers to Restart Recruitment for the COVA Phase 2-3 Study with Sarconeos (BIO101) in COVID-19
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / November 15, 2021 / Biophytis SA (NasdaqCM:BPTS, Euronext Growth Paris: ALBPS) (the...
Angle PLC Announces Appointment of Chief Medical Officer
Todd Druley, M.D., PhD. brings deep experience of building a medical team and establishing oncology assays, most recently at ArcherDX,...
New Study Finds That Use of Masimo SedLine® PSi and DSA May Significantly Reduce Postoperative Delirium
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in Frontiers in Neurology in which...